Alzheimer's Diagnosis, Treatment, and Life Beyond

How is Alzheimer's Diagnosed?

There is no single test that diagnoses every case of Alzheimer’s.

Instead, doctors usually put several pieces of information together. They may ask when the changes began, how often they happen, whether they are getting worse, and how they are affecting everyday life, often asking for observations from a close family member or friend when the person does not recognize the changes themselves.

Doctors may use brief assessments to look at memory, attention, language, and problem-solving, alongside reviewing medications and asking about mood, sleep, movement, and behavior.

To investigate other possible causes of cognitive changes, doctors use blood tests and brain imaging like MRI or CT scans.

Diagnosis is also shifting to look at the biology of the disease itself. Instead of relying only on outward symptoms, doctors can increasingly look for the actual physical signs of Alzheimer’s in the brain or body using specialized scans, spinal fluid tests, and newer blood tests that detect proteins linked to the disease.

Blood-based tests are particularly helpful because they are much easier to access than brain scans or spinal fluid testing, though availability varies widely depending on your local healthcare system. Confirming the underlying disease through these tests is becoming more important as treatments become more targeted.

Recognizing the Symptoms of Alzheimer's Disease

Alzheimer’s disease doesn’t always announce itself through dramatic changes. Sometimes, it begins with small moments that are easy to overlook. A familiar name becomes difficult to recall, a conversation is repeated minutes later, or a routine task suddenly feels more complicated than it once did.

As the condition progresses, these changes can become more noticeable. Someone may struggle to follow conversations, lose their way in familiar places, forget important appointments, or find it increasingly difficult to manage everyday responsibilities. Changes in mood, judgment, or personality may also emerge, sometimes causing frustration, anxiety, or withdrawal from activities they once enjoyed.

Early Alzheimer's Signs To Watch For

Memory Lapses

Forgetting recent conversations, repeating questions or missing important appointments.

Communication Difficulties

Struggling to find familiar words or follow conversations that once felt effortless.

Losing Familiarity

Becoming confused in familiar surroundings or getting lost on well-known routes.

Everyday Tasks Become Harder

Finding it difficult to manage bills, medication, cooking or other routine responsibilities.

Changes in Judgement

Having more difficulty making decisions, solving problems or recognizing potential risks.

Emotional and Social Changes

Experiencing shifts in mood or personality, anxiety or withdrawal from enjoyable activities.

What makes Alzheimer’s particularly challenging is that its symptoms extend beyond memory loss. It can gradually affect how a person communicates, makes decisions, understands their surroundings, and connects with others.

However, not every memory lapse is a sign of Alzheimer’s. Stress, poor sleep, medication effects, depression, and other medical conditions can cause similar difficulties.

The important distinction is whether these changes become persistent, worsen over time, or begin interfering with daily life.

Recognizing these signs early creates an opportunity to seek medical evaluation, understand what’s happening, and access appropriate support. Above all, it helps families respond with patience and understanding rather than confusion or judgment.

Alzheimer's Treatment and Support

There is currently no cure for Alzheimer’s, but treatment and support can help manage symptoms and maintain quality of life. Healthy habits, such as: managing blood pressure, cholesterol, and blood sugar, staying physically active, eating a balanced diet, treating hearing and vision problems, staying socially connected, avoiding smoking and limiting alcohol, cannot promise that someone will never develop dementia, but they may help support brain health and potentially reduce or delay risk.

Traditional Alzheimer’s medicines, sometimes prescribed to help manage symptoms involving memory, thinking, or behavior, can offer temporary relief or help slow down how quickly symptoms worsen. More recently, newer targeted therapies have been developed to clear sticky protein build-ups from the brain. These are generally intended for people in the earliest stages of Alzheimer’s who have confirmed plaque build-up.

Clinical trials such as the Lecanemab in Early Alzheimer’s Disease — New England Journal of Medicine (2023) show they can modestly slow down how fast the disease progresses, though they are not cures.

Because these treatments require regular infusions, careful monitoring with brain scans, and come with risks like potential brain swelling or bleeding, deciding to use them involves a very careful conversation with a doctor about potential benefits, risks, overall health, and other medications like blood thinners. Access, approval, and cost also vary widely between different countries and healthcare systems.

Beyond medication, practical and emotional support are vital. Often, the most meaningful help is very hands-on: assisting with appointments, organizing medications, adjusting daily routines, or helping a person stay involved in activities they love.

Counseling, therapy, and support groups can also offer a lifeline for families dealing with anxiety, grief, changing responsibilities, and the everyday uncertainties of the condition.

Life Beyond The Diagnosis

An Alzheimer’s diagnosis can change a person’s life, but it does not erase who they are. People living with Alzheimer’s can still have meaningful relationships, enjoy familiar hobbies, laugh with family, experience comfort, and take part in moments that matter to them.

Families can also find new ways to communicate, create supportive routines, and make everyday life less stressful. Planning ahead can help too, which might mean discussing future care preferences, financial decisions, legal arrangements, medication, transportation, or safety while the person can still clearly express their wishes.

Alzheimer’s is a complex disease that affects the brain and reaches into almost every part of a person’s life and the lives of those around them. That is why it is important to look beyond the word ‘forgetfulness’. Persistent changes in memory, thinking, behavior, or everyday abilities deserve attention.

When those changes are noticed, getting assessed can help identify possible causes, provide clearer answers, and connect the person and their family with appropriate care and support. A person is always more than their diagnosis.

References

  1. Dhana K, Beck T, Desai P, Wilson RS, Evans DA, Rajan KB. Prevalence of Alzheimer’s disease dementia in the 50 US states and 3142 counties: A population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics. Alzheimers Dement. 2023 Oct;19(10):4388-4395. doi: 10.1002/alz.13081. Epub 2023 Jul 17. PMID: 37458371; PMCID: PMC10593099.
  2. Scheltens P, De Strooper B, Kivipelto M et al., Alzheimer’s disease. The Lancet, 2021; 397, 1577-1590.
  3. Alzheimer’s Association. 2025 Alzheimer’s disease facts and figures. Alzheimers Dement. 2025;21(4):e70235. doi:10.1002/alz.70235.
  4. Cummings J, Apostolova L, Rabinovici GD, et al., Lecanemab: Appropriate use recommendations. J Prev Alzheimers Dis. 2023;10(3):362–377. doi:10.1016/j.tjpad.2023.05.016
  5. Jack CR Jr, Bennett DA, Blennow K, et al., NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 2018;14(4):535–562. doi:10.1016/j.jalz.2018.02.018
  6. Livingston G, Huntley J, Sommerlad A, et al., Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572–628. doi:10.1016/S0140-6736(24)01296-0
  7. McKhann GM, Knopman DS, Chertkow H, et al., The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.005
  8. Mintun MA, Lo AC, Duggan Evans C, et al., Donanemab in early Alzheimer’s disease. N Engl J Med. 2021;384(18):1691–1704. doi:10.1056/NEJMoa2100708
  9. National Institute on Aging. What Is Alzheimer’s Disease? March, 3 2025. Available at:https://www.nia.nih.gov/health/alzheimers-and-dementia/what-alzheimers-disease. Accessed September 13, 2026.
  10. Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, Okrahvi HR, Paczynski M, Schindler SE, Teunissen CE, Zetterberg H, Carrillo MC, Edelmayer RM, Mahinrad S, McAteer MB, Kahale LA, Pahlke S, Tampi MP. Alzheimer’s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer’s disease within specialized care settings. Alzheimers Dement. 2025 Jul;21(7):e70535. doi: 10.1002/alz.70535. PMID: 40729527; PMCID: PMC12306682.
  11. Sims JR, Zimmer JA, Evans CD, et al., Donanemab in early symptomatic Alzheimer disease. N Engl J Med. 2023;388(20):1907–1918. doi:10.1056/NEJMoa2302392
  12. van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. PMID: 36449413.
  13. World Health Organization. Dementia. July, 3 2026. Available at:https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed September 13, 2026.

Nothing on this page is medical advice. Always discuss your options with your own care team.

HealthfulHeroes.com is maintained by Healthful Stories, Inc. (EIN 85-3699881), a Seattle-based non-profit 501(c)(3) patient advocacy organization. This site is purpose-built to chronicle individual health journeys to inspire and empower, reducing global suffering, one life at a time.